VICIS was created in 2013 to develop an improved football helmet. The company leverages technology initially developed at University of Washington. VICIS investors include several prominent spine and neurological surgeons, current and former NFL players, the W Fund, Alliance of Angels, angelMD, and Trilogy Equity Partners. VICIS founders are Per Reinhall, PhD, Professor and Chair of Mechanical Engineering at UW; Samuel Browd, MD, PhD, Pediatric Neurosurgeon and Medical Director of the Sports Concussion Program at Seattle Children's Hospital; and Dave Marver, CEO and veteran of the medical technology industry.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/20/16 | $8,000,000 | Seed |
Robert Nelsen Roger Staubach | undisclosed |
| 04/18/17 | $1,200,000 | |||
| 06/13/17 | $10,000,000 |
Harry Fath | undisclosed | |
| 11/01/18 | $28,500,000 | Series B |
Rx3 Ventures | undisclosed |
| 02/01/19 | undisclosed | Series B Extension |
Rx3 Ventures | undisclosed |
